<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Ethinyl Estradiol</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00977</strong>&#160; (APRD00691)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A semisynthetic alkylated estradiol with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally and is often used as the estrogenic component in oral contraceptives [PubChem]. Ethinyl estradiol is marketed mostly as a combination oral contraceptive under several brand names such as Alesse, Tri-Cyclen, Triphasil, and Yasmin. The <span class="caps">FDA</span> label includes a black box warning that states that combination oral contraceptives should not be used in women over 35 years old who smoke due to the increased risk of serious cardiovascular side effects.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00977/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00977/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00977.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00977.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00977.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00977.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00977.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00977">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>17 alpha-Ethinylestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>17 alpha-Ethynylestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>17 alpha-Ethynyloestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>17-ethinyl-3,17-estradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>17-ethinyl-3,17-oestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>17-ethinylestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>17alpha-Ethinyl estradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>17&#945;-ethynylestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Ethinyl-Oestranol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Ethinylestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Ethinylestradiolum</td><td>Latin</td><td>INN</td></tr><tr><td>Ethinylestriol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Ethinyloestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Ethynyl estradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Ethynylestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Ethynyloestradiol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Etinilestradiol</td><td>Spanish</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Estinyl</td><td>Schering</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Alesse</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Amethyst</td><td>Levonorgestrel + Ethinyl Estradiol</td></tr><tr><td>Apri</td><td>Ethinyl Estradiol + desogestrel</td></tr><tr><td>Aviane</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Brevicon</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Cyclen</td><td>Ethinyl Estradiol + Norgestimate</td></tr><tr><td>Demulen</td><td>Ethinyl Estradiol + Ethynodiol Diacetate</td></tr><tr><td>Desogen</td><td>Ethinyl Estradiol + desogestrel</td></tr><tr><td>Diane-35</td><td>Cyproterone Acetate + Ethinyl Estradiol</td></tr><tr><td>Evra</td><td>Ethinyl Estradiol + Norelgestromin</td></tr><tr><td>femhrt</td><td>Norethindrone + Ethinyl Estradiol</td></tr><tr><td>Femhrt 1/5</td><td>Ethinyl Estradiol + Norethindrone Acetate</td></tr><tr><td>Femodene</td><td>Ethinyl Estradiol + gestodene</td></tr><tr><td>Femodette</td><td>Ethinyl Estradiol + gestodene</td></tr><tr><td>Jinteli</td><td>Norethindrone + Ethinyl Estradiol</td></tr><tr><td>JINTELI</td><td>Norethindrone + Ethinyl Estradiol</td></tr><tr><td>Jolessa</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Junel</td><td>norethindrone acetate+ Ethinyl Estradiol</td></tr><tr><td>Kariva</td><td>Ethinyl Estradiol + desogestrel</td></tr><tr><td>Lessina</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Lo Minastrin</td><td>Norethindrone acetate, ethinyl estradiol, ferrous fumarate</td></tr><tr><td>Lo-Femenal</td><td>Ethinyl Estradiol + Norgestrel</td></tr><tr><td>Loestrin</td><td>Ethinyl Estradiol + Norethindrone Acetate</td></tr><tr><td>Lutera</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Lybrel</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Marvelon</td><td>Desogestrel + Ethinyl Estradiol</td></tr><tr><td>Mercilon</td><td>Ethinyl Estradiol + desogestrel</td></tr><tr><td>Microgestin</td><td>norethindrone acetate+ Ethinyl Estradiol</td></tr><tr><td>Min-Ovral</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Minestrin 1/20</td><td>Ethinyl Estradiol + Norethindrone Acetate</td></tr><tr><td>Minulet</td><td>Ethinyl Estradiol + gestodene</td></tr><tr><td>Mircette</td><td>Ethinyl Estradiol + desogestrel</td></tr><tr><td>Neo Mens Tab</td><td>Ethinyl Estradiol + Ethisterone</td></tr><tr><td>Nuvaring</td><td>Ethinyl Estradiol + Etonogestrel</td></tr><tr><td>Ocella</td><td>Drospirenone + Ethinyl Estradiol</td></tr><tr><td>Ortho</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho-Cept</td><td>Desogestrel + Ethinyl Estradiol</td></tr><tr><td>Ovcon</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ovral</td><td>Ethinyl Estradiol + Norgestrel</td></tr><tr><td>Preven</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Quartette</td><td>Levonorgestrel/Ethinyl Estradiol + Ethinyl Estradiol</td></tr><tr><td>Quasense</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Seasonale</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Seasonique</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Select 1/35</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Sronyx</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Synphasic</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Tri-Cyclen</td><td>Ethinyl Estradiol + Norgestimate</td></tr><tr><td>Tri-Cyclen Lo</td><td>Ethinyl Estradiol + Norgestimate</td></tr><tr><td>Triphasil</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Triquilar</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Yasmin</td><td>Drospirenone + Ethinyl Estradiol</td></tr><tr><td>Yasminelle</td><td>Drospirenone + Ethinyl Estradiol</td></tr><tr><td>Yaz</td><td>Drospirenone + Ethinyl Estradiol</td></tr><tr><td>Zarah</td><td>Drospirenone + Ethinyl Estradiol</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/estrogens">Estrogens</a></li></ul></td></tr><tr><th>CAS number</th><td>57-63-6</td></tr><tr><th>Weight</th><td>Average: 296.4034<br>Monoisotopic: 296.177630012</td></tr><tr><th>Chemical Formula</th><td>C<sub>20</sub>H<sub>24</sub>O<sub>2</sub></td></tr><tr><th>InChI Key</th><td>BFPYWIDHMRZLRN-RHKZOZTBNA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/s2</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(1S,10R,11S,14R,15S)-14-ethynyl-15-methyltetracyclo[8.7.0.0&#178;,&#8311;.0&#185;&#185;,&#185;&#8309;]heptadeca-2(7),3,5-triene-5,14-diol</div></td></tr><tr><th>SMILES</th><td><div class="wrap">[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00977.gif?1265922773">show</a>(9.42 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Lipids</td></tr><tr><th>Class</th><td>Steroids and Steroid Derivatives</td></tr><tr><th>Subclass</th><td>Hydroxysteroids</td></tr><tr><th>Direct parent</th><td>Hydroxysteroids</td></tr><tr><th>Alternative parents</th><td>Phenanthrenes and Derivatives; Tetralins; Phenols and Derivatives; Ynones; Tertiary Alcohols; Cyclic Alcohols and Derivatives; Enols; Polyamines</td></tr><tr><th>Substituents</th><td>phenanthrene; tetralin; phenol derivative; ynone; benzene; cyclic alcohol; tertiary alcohol; polyamine; enol; alcohol</td></tr><tr><th>Classification description</th><td>This compound belongs to the hydroxysteroids. These are compounds containing an steroid backbone, with at least one hydrogen substituted by an hydroxyl group.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For treatment of moderate to severe vasomotor symptoms associated with the menopause, female hypogonadism, prostatic carcinoma-palliative therapy of advanced disease, breast cancer, as an oral contraceptive, and as emergency contraceptive.</td></tr><tr><th>Pharmacodynamics</th><td>Ethinyl estradiol is a synthetic derivative of the natural estrogen estradiol. It is one of two estrogens currently used in oral contraceptive pills. The other, mestranol, is converted to ethinyl estradiol before it is biologically active. Ethinyl estradiol and norethindrone are used together as an oral contraceptive agent.</td></tr><tr><th>Mechanism of action</th><td>Estrogens diffuse into their target cells and interact with a protein receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. This cascade is initiated by initially binding to the estrogen receptors. The combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (GnRH).</td></tr><tr><th>Absorption</th><td>Rapid and complete absorption follows oral intake of ethinyl estradiol (bioavailability 43%).</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>97%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic. Quantitatively, the major metabolic pathway for ethinyl estradiol, both in rats and in humans, is aromatic hydroxylation, as it is for the natural estrogens.</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Ethinyl Estradiol</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002793" target="_blank">Cytochrome P450 2C9</a></li>
<li><a href="/biodb/bio_entities/BE0002638" target="_blank">Cytochrome P450 3A4</a></li>
<li><a href="/biodb/bio_entities/BE0003536" target="_blank">Cytochrome P450 2C19</a></li>
<li><a href="/biodb/bio_entities/BE0002433" target="_blank">Cytochrome P450 1A2</a></li></ul></td><td><a href="/metabolites/DBMET01270">2&#946;-OH-17&#946;-ethinylestradiol</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1430">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td>36 +/- 13 hours</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>Oral, mouse LD<sub>50</sub>: 1737 mg/kg. Symptoms of overdose include nausea and vomiting, and withdrawal bleeding may occur in females. The FDA label includes a black box warning that states that combination oral contraceptives with ethinyl estradiol should not be used in women over 35 years old who smoke due to the increased risk of serious cardiovascular side effects. </td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9965</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.8546</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.8638</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.6892</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9006</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9449</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.84</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7178</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.715</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Inhibitor</td>
        <td>0.8941</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9186</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9506</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.6641</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Inhibitor</td>
        <td>0.5224</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.6776</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9155
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8519
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9879
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.4584 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8805
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Inhibitor 
        </td>
        <td>
            0.5788
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Schering corp sub schering plough corp</li>
<li>Pharmacia and upjohn co</li>
<li>Organon usa inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li>Barr Pharmaceuticals</li>
<li><a href="http://www.bayerhealthcare.com">Bayer Healthcare</a></li>
<li>Dept Health Central Pharmacy</li>
<li><a href="http://www.duramed.ca">Duramed</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li>NV Organon</li>
<li><a href="http://www.organonshop.com">Organon Pharmaceuticals</a></li>
<li><a href="http://www.ortho-mcneil.com">Ortho Mcneil Janssen Pharmaceutical Inc.</a></li>
<li><a href="http://www.ortho-mcneil.com">Ortho-McNeil-Janssen Pharmaceuticals Inc.</a></li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.prasco.com">Prasco Labs</a></li>
<li><a href="http://www.schering.de">Schering Corp.</a></li>
<li><a href="http://www.spectrumpharm.com">Spectrum Pharmaceuticals</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Cream</td><td>Intravaginal</td><td></td></tr><tr><td>Insert, extended release</td><td>Transdermal</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Ethinyl estradiol powder</td><td>140.0USD</td><td>g</td></tr><tr><td>Ortho-Cyclen (28) 28 0.25-35 mg-mcg tablet Disp Pack</td><td>38.99USD</td><td>disp</td></tr><tr><td>Ortho tri-cyclen lo tablet</td><td>2.68USD</td><td>tablet</td></tr><tr><td>Ortho-cyclen 28 tablet</td><td>1.13USD</td><td>tablet</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>142-144</td><td>Inhoffen, H.H. and Hohlweg, W.; U.S. Patent 2,265,976; December 9, 1941; assigned to Schering Corp.</td></tr><tr><td>water solubility</td><td>11.3 mg/L (at 27 &#176;C)</td><td>YALKOWSKY,SH &amp; DANNENFELSER,RM (1992)</td></tr><tr><td>logP</td><td>3.67</td><td>HANSCH,C ET AL. (1995)</td></tr><tr><td>logS</td><td>-4.3</td><td>ADME Research, USCD</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>6.77e-03 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>3.63</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>3.9</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-4.6</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>10.33</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>-1.7</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>40.46</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>87.37</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>34.53</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Andreas Sachse, &#8220;Method of female hormonal contraception using a fixed extended cycle hormonal preparation containing dienogest and ethinyl estradiol.&#8221; U.S. Patent US20060079491, issued April 13, 2006.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=20060079491&amp;tbm=pts" target="_blank">US20060079491 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li><span class="caps">FDA</span> label.</li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D00554" target="_blank">D00554 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C07534" target="_blank">C07534 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=4903" target="_blank">4903 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL691" target="_blank">CHEMBL691 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP001018" target="_blank">DAP001018 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA449527" target="_blank">PA449527 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=28231" target="_blank">28231 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/estinyl.htm" target="_blank">http://www.rxlist.com/cgi/generic/estinyl.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Ethinylestradiol" target="_blank">Ethinylestradiol <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>AHFS Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB00977.pdf?1371680618">show</a>(470 KB)</td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB00977.pdf?1265922743">show</a>(73.9 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>Increased thrombotic risk due to estrogen</td></tr><tr><td><a href="/drugs/DB01223">Aminophylline</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01351">Amobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01060">Amoxicillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00415">Ampicillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00701">Amprenavir</a></td><td>Ritonavir could decrease the contraceptive efficacy</td></tr><tr><td><a href="/drugs/DB01125">Anisindione</a></td><td>Increased thrombotic risk due to estrogen</td></tr><tr><td><a href="/drugs/DB00673">Aprepitant</a></td><td>Aprepitant could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB01352">Aprobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB06697">Artemether</a></td><td>Artemether may decrease the effectiveness of ethinyl estradiol by increasing its metabolism via CYP3A4. Consider an alternate non-hormonal means of contraception during artemether therapy. </td></tr><tr><td><a href="/drugs/DB01061">Azlocillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00355">Aztreonam</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB01602">Bacampicillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB06769">Bendamustine</a></td><td>Increases levels of bendamustine by decreasing metabolism. Ethinyl Estradiol is a CYP1A2 inhibitor and concurrent administration may result in elevated plasma concentrations of bendamustine. </td></tr><tr><td><a href="/drugs/DB00559">Bosentan</a></td><td>Bosentan may decrease the contraceptive effect of ethinyl estradiol. Hormonal contraception should not be relied on alone during concomitant therapy with bosentan.</td></tr><tr><td><a href="/drugs/DB00237">Butabarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00241">Butalbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01353">Butethal</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>Carbamazepine may decrease the contraceptive effect of ethinyl estradiol. Hormonal contraception should not be relied on alone during concomitant therapy with carbamazepine.</td></tr><tr><td><a href="/drugs/DB00766">Clavulanate</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB01147">Cloxacillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td>Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Estrogens). Administer estrogen-based oral contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant. Consider alternatives in order to avoid this combination when possible, due to the risk for impaired contraceptive effectiveness. Ethinyl estradiol patches and vaginal rings may also be somewhat impacted by this interaction, though the extent and significance of such an interaction is uncertain.</td></tr><tr><td><a href="/drugs/DB01000">Cyclacillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00091">Cyclosporine</a></td><td>The contraceptive increases the effect and toxicity of cyclosporine</td></tr><tr><td><a href="/drugs/DB00618">Demeclocycline</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00485">Dicloxacillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00266">Dicoumarol</a></td><td>Increased thrombotic risk due to estrogen</td></tr><tr><td><a href="/drugs/DB00254">Doxycycline</a></td><td>Doxycycline may decrease the contraceptive effect of ethinyl estradiol.</td></tr><tr><td><a href="/drugs/DB00651">Dyphylline</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB06210">Eltrombopag</a></td><td>Affects hepatic CYP1A2 metabolism, increases Eltrombopag level or affect.</td></tr><tr><td><a href="/drugs/DB00754">Ethotoin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01628">Etoricoxib</a></td><td>Etoricoxib may increase the levels of ethinyl estradiol.</td></tr><tr><td><a href="/drugs/DB00301">Flucloxacillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00400">Griseofulvin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01354">Heptabarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00739">Hetacillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB01355">Hexobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01026">Ketoconazole</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00555">Lamotrigine</a></td><td>The oral contraceptive decreases the effect of lamotrigine</td></tr><tr><td><a href="/drugs/DB00532">Mephenytoin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00931">Methacycline</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00474">Methohexital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00849">Methylphenobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01603">Meticillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00948">Mezlocillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB01017">Minocycline</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00745">Modafinil</a></td><td>Modafinil may decrease the contraceptive effect of ethinyl estradiol. Hormonal contraception should not be solely relied on during concomitant therapy with modafinil.</td></tr><tr><td><a href="/drugs/DB00607">Nafcillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00220">Nelfinavir</a></td><td>Ritonavir could decrease the contraceptive efficacy</td></tr><tr><td><a href="/drugs/DB00713">Oxacillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00776">Oxcarbazepine</a></td><td>Oxcarbazepine may decrease the contraceptive effect of ethinyl estradiol. Hormonal contraception should not be solely relied upon during concomitant therapy with oxcarbazepine.</td></tr><tr><td><a href="/drugs/DB01303">Oxtriphylline</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00595">Oxytetracycline</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00312">Pentobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00319">Piperacillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB01604">Pivampicillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00860">Prednisolone</a></td><td>The estrogenic agent, ethinyl estradiol, may increase the effect of the corticosteroid, prednisolone.</td></tr><tr><td><a href="/drugs/DB00635">Prednisone</a></td><td>The estrogenic agent, ethinyl estradiol, may increase the effect of corticosteroid, prednisone.</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00481">Raloxifene</a></td><td>Association not recommended</td></tr><tr><td><a href="/drugs/DB00615">Rifabutin</a></td><td>Rifabutin may decrease the contraceptive effect of ethinyl estradiol. Hormonal contraception should not be solely relied on alone during concomitant therapy with rifabutin.</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01201">Rifapentine</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00503">Ritonavir</a></td><td>Ritonavir could decrease the contraceptive efficacy</td></tr><tr><td><a href="/drugs/DB01301">Rolitetracycline</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB06201">Rufinamide</a></td><td>Rufinamide decreases plasma concentrations of ethinyl estradiol, thus consider therapy modification </td></tr><tr><td><a href="/drugs/DB00418">Secobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01323">St. John's Wort</a></td><td>St. John's Wort could reduce the contraceptive effect</td></tr><tr><td><a href="/drugs/DB00864">Tacrolimus</a></td><td>Ethinyl estradiol may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Ethinyl estradiol therapy is initiated, discontinued or altered.</td></tr><tr><td><a href="/drugs/DB00306">Talbutal</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01606">Tazobactam</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00759">Tetracycline</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00277">Theophylline</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00599">Thiopental</a></td><td>Thiopental may decrease the effect of Ethinyl estradiol. Contraceptive failure may occur. Alternative nonhomomonal contraception should be used during concomitant therapy. </td></tr><tr><td><a href="/drugs/DB01607">Ticarcillin</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00932">Tipranavir</a></td><td>Tipranavir, co-administered with Ritonavir, decreases Ethinyl estradiol concentrations. Ethinyl estradiol may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Use an alternate form of contraception or monitor for estrogen deficiency if Ethinyl estradiol is used for hormone replacement therapy. </td></tr><tr><td><a href="/drugs/DB00697">Tizanidine</a></td><td>Ethinyl estradiol may increase the serum concentration of tizanidine. Monitor for changes in the therapeutic and adverse effects of tizanidine if ethinyl estradiol is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00273">Topiramate</a></td><td>Topiramate may decrease the effect of the oral contraceptive, Ethinyl estradiol. An alternate form of contraception should be used during concomitant therapy.</td></tr><tr><td><a href="/drugs/DB00755">Tretinoin</a></td><td>Oral Tretinoin may decrease the effect of the oral contraceptive, Ethinyl Estradiol. An alternate form of contraception should be used during concomitant therapy. </td></tr><tr><td><a href="/drugs/DB00197">Troglitazone</a></td><td>Possible loss of contracepitve effect</td></tr><tr><td><a href="/drugs/DB01586">Ursodeoxycholic acid</a></td><td>Estrogens decreases the effect of ursodiol</td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>Ethinyl estradiol may alter the anticoagulant effect of warfarin. Concomitant therapy should be avoided. Monitor for changes in coagulation status if ethinyl estradiol is initiated, discontinued or dose changed.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>